tirzepatide launch Eli Lilly gets nod to weight-loss drug in Hong Kong - Bloomberg News Lilly says new diabetes launch

revenue generated by GLP-1 products from launch through 2024 in comparison to the total combined gain in market capitalization for Eli Lilly and Novo Nordisk since the first product launch for each company (Ozempic 12/5/17 and Mounjaro 5/13/22) and through the end of 2024

They are also used for people living with obesity (defined as a body mass index, or BMI, of 30 or more) or overweight individuals (BMI of 27 or more) who have related health issues like high blood pressure or cholesterol

Metabolic Support: Some peptides, including tirzepatide, target GIP receptors that influence fat storage and energy metabolism

GIP), released during meals with increasing glucose levels in the blood are insulinotropic that are responsible for about three quarters of total insulin secretion 6

These medications are approved to treat Type 2 diabetes

In such cases, abdominal ultrasound remains the preferred initial imaging modality